The Office of Research is pleased to announce two funding opportunities: 1.) A Request for Proposals (RFP) has been issued for a new Office of Research funded Centers of Excellence. A Letter of Intent (LOI) must be submitted no later than 11/1/24. Go HERE for the RFP and LOI details. 2.) Office of Research Bridge Fund Award applications will be accepted until 12/1/24. Go HERE for more information.

Institutional Biosafety Committee

 

The Tulane University Institutional Biosafety Committee (IBC) is a university-wide committee responsible for reviewing research activities utilizing recombinant DNA (rDNA) and/or infectious agents, assuring the safe conduct of research, assessing decontamination and biocontainment levels, and ensuring research is done in compliance with government and institution regulations. The use of rDNA or infectious agents has the potential of endangering the health of humans an animals and affecting the environment. Federal regulations require that all procedures involving the use of rDNA, which according to the "NIH Guidelines for Use of Recombinant or Synthetic Nucleic Acid Molecules" are Non-Exempt, undergo review by the IBC.

This site describes the current policies of Tulane University’s IBC, how it regulates research and the procedures to obtain IBC approval. Information hereby presented is intended to help investigators, IBC members and Biosafety Officers comply with institution, federal, state and local regulations.